Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
289.6 INR | +3.37% | +9.80% | +16.00% |
Apr. 18 | India's Biocon developing its own version of Wegovy, clinical trial likely next year | RE |
Apr. 18 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.00% | 4.02B | |
-1.32% | 105B | |
+3.98% | 97.5B | |
+1.86% | 22.19B | |
-16.57% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.33% | 14.52B | |
+5.59% | 14.09B | |
+27.75% | 10.99B |
- Stock Market
- Equities
- BIOCON Stock
- News Biocon Limited
- Transcript : Biocon Limited, Q1 2014 Earnings Call, Jul 26, 2013